Myelodysplastic Syndromes
Showing NaN - NaN of 35
MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndromes
- Magrolimab
- +2 more
-
Birmingham, Alabama
- +168 more
Dec 7, 2022
Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia (AML)
- +3 more
-
Birmingham, Alabama
- +26 more
Sep 12, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Acute Leukemia, MDS Trial in Atlanta (Interferon gamma (IFN?)-primed human bone marrow-derived mesenchymal stromal cells)
Recruiting
- Acute Leukemia
- Myelodysplastic Syndromes
- Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
-
Atlanta, Georgia
- +2 more
Jul 15, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- BPX-501 dose 1
- +5 more
-
Atlanta, Georgia
- +7 more
Jul 10, 2022
Acute Myeloid Leukemia, MDS, Glioblastoma Multiforme Trial in United States (DSP-7888 Dosing Emulsion)
Completed
- Acute Myeloid Leukemia
- +8 more
- DSP-7888 Dosing Emulsion
-
Denver, Colorado
- +7 more
Apr 4, 2022
MDS Trial in Worldwide (Luspatercept, Placebo)
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))
Recruiting
- Acute Myeloid Leukemia
- +4 more
- TregGraft (Orca-T)
-
Duarte, California
- +13 more
Oct 28, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (OrcaGraft (Orca-Q))
Recruiting
- Acute Myeloid Leukemia
- +3 more
- OrcaGraft (Orca-Q)
-
Duarte, California
- +7 more
Oct 28, 2021
Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)
Completed
- Hematologic Malignancy
- +4 more
-
Washington, District of Columbia
- +12 more
Jul 20, 2021
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
MDS Trial in Canada, United States (anti-thymocyte globulin)
Completed
- Myelodysplastic Syndromes
- anti-thymocyte globulin
-
Washington, District of Columbia
- +27 more
Jan 24, 2021
Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in United States (arsenic trioxide)
Terminated
- Leukemia
- +2 more
- arsenic trioxide
-
Tucson, Arizona
- +7 more
Oct 2, 2020
MDS Trial in United States (ARRY-614, p38/Tie2 inhibitor; oral)
Completed
- Myelodysplastic Syndromes
- ARRY-614, p38/Tie2 inhibitor; oral
-
Tampa, Florida
- +3 more
Sep 4, 2020
MDS Trial in Tampa, Atlanta, Houston (ARRY-614, p38/Tie2 inhibitor; oral)
Completed
- Myelodysplastic Syndromes
- ARRY-614, p38/Tie2 inhibitor; oral
-
Tampa, Florida
- +2 more
Sep 4, 2020
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
Leukemia, MDS Trial in Atlanta, Baltimore (bevacizumab, cytarabine, mitoxantrone HCl)
Completed
- Leukemia
- Myelodysplastic Syndromes
- bevacizumab
- +2 more
-
Atlanta, Georgia
- +2 more
Oct 15, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)
Completed
- Leukemia
- +4 more
- therapeutic allogeneic lymphocytes
- +6 more
-
Denver, Colorado
- +13 more
Sep 13, 2019
Leukemia, MDS Trial in United States (biological, drug, procedure, radiation)
Terminated
- Leukemia
- Myelodysplastic Syndromes
- anti-thymocyte globulin
- +4 more
-
Tampa, Florida
- +8 more
Dec 3, 2017
Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic Trial in France, United States
Completed
- Leukemia, Myelocytic, Acute
- +3 more
- Tacrolimus
- +2 more
-
Duarte, California
- +23 more
Feb 8, 2016
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Atlanta, Baltimore, Philadelphia (drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- cyclophosphamide
- +5 more
-
Atlanta, Georgia
- +2 more
Sep 2, 2015
Bone Marrow and Blood Samples From Leukemia or Other
Completed
- Leukemia
- +2 more
- cytogenetic analysis
- fluorescence in situ hybridization
-
Mobile, Alabama
- +279 more
Mar 5, 2015
S9910, Collecting and Storing Blood and Bone Marrow Samples From
Completed
- Leukemia
- +2 more
- biologic sample preservation procedure
-
Ft. Smith, Arkansas
- +291 more
Mar 5, 2015
Leukemia, MDS Trial in United States (anti-thymocyte globulin, cyclosporine)
Completed
- Leukemia
- Myelodysplastic Syndromes
- anti-thymocyte globulin
- cyclosporine
-
Mobile, Alabama
- +93 more
Mar 5, 2015
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- ruxolitinib phosphate
- +2 more
-
Birmingham, Alabama
- +23 more
Oct 22, 2014